Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels

Title
Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels
Authors
Keywords
-
Journal
PAIN
Volume 153, Issue 5, Pages 1091-1106
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2012-03-17
DOI
10.1016/j.pain.2012.02.015

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now